Carbidopa and levodopa and Clotrimazole drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Carbidopa and levodopa (carbidopa; levodopa) and Clotrimazole (clotrimazole). Common drug interactions include alanine aminotransferase increased among females and cough among males.

The phase IV clinical study analyzes what interactions people have when they take Carbidopa and levodopa and Clotrimazole. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Carbidopa and levodopa?

Carbidopa and levodopa has active ingredients of carbidopa; levodopa. It is often used in parkinson's disease. eHealthMe is studying from 6,152 Carbidopa and levodopa users. Check the latest studies of Carbidopa and levodopa.

What is Clotrimazole?

Clotrimazole has active ingredients of clotrimazole. It is often used in thrush. eHealthMe is studying from 13,947 Clotrimazole users. Check the latest studies of Clotrimazole.



On Jul, 13, 2026

15 people who take Carbidopa and levodopa and Clotrimazole together, and have interactions are studied.

Carbidopa and levodopa and Clotrimazole drug interactions.

What are the common drug interactions of Carbidopa And Levodopa and Clotrimazole, by gender? *:

female:

  1. Alanine aminotransferase increased
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  3. Aspartate aminotransferase increased
  4. Blood alkaline phosphatase increased
  5. Blood chloride decreased
  6. Blood cholesterol increased
  7. Blood sodium decreased
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

male:

  1. Cough
  2. Infection
  3. Gait disturbance
  4. Injury
  5. Masked facies (mask like facial expression, display little facial expression)
  6. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  7. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  8. Muscle rigidity (muscle stiffness)
  9. Staring (a prolonged gaze or fixed look)
  10. Tardive dyskinesia (a disorder that involves involuntary movements)

What are the common drug interactions of Carbidopa And Levodopa and Clotrimazole, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Alanine aminotransferase increased
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  3. Aspartate aminotransferase increased
  4. Blood alkaline phosphatase increased
  5. Blood chloride decreased
  6. Blood cholesterol increased
  7. Blood sodium decreased
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  10. Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)

40-49:

n/a

50-59:

  1. Hepatitis (inflammation of the liver)
  2. Hypoxia (low oxygen in tissues)
  3. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  4. Blood creatine phosphokinase increased

60+:

  1. Cough
  2. Infection
  3. Sputum discoloured
  4. Nonspecific reaction (unspecified reaction)
  5. Aspartate aminotransferase increased
  6. Peripheral swelling
  7. Prostatic specific antigen increased
  8. Urinary tract infection
  9. Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)

What are the existing conditions these people have? *

  1. High Blood Pressure: 3 people, 20.00%
  2. Muscle Spasms (muscle contraction): 3 people, 20.00%
  3. Pain: 2 people, 13.33%
  4. Nasopharyngitis (inflammation of the nasopharynx): 2 people, 13.33%
  5. Hypersensitivity: 2 people, 13.33%
  6. On And Off Phenomenon: 2 people, 13.33%
  7. Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 13.33%
  8. Depression: 2 people, 13.33%
  9. Cough: 1 person, 6.67%
  10. Conversion Disorder (neurological symptoms, such as numbness, blindness, paralysis, or fits without a definable organic cause): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Carbidopa and levodopa and Clotrimazole?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Carbidopa and levodopa and Clotrimazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Carbidopa and levodopa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Clotrimazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Carbidopa and levodopa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clotrimazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on carbidopa; levodopa and clotrimazole (the active ingredients of Carbidopa and levodopa and Clotrimazole, respectively), and Carbidopa and levodopa and Clotrimazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: